IE
ABEO icon

Israel Englander’s Abeona Therapeutics ABEO Stock Holding History

Israel Englander’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,100
Closed -$240K – 5806
2024
Q1 		$240K Buy
+33,100
New +$210K ﹤0.01% 5272
2018
Q1 		– Sell
-4,212
Closed -$1.67M – 3584
2017
Q4 		$1.67M Buy
+4,212
New +$1.74M ﹤0.01% 2392

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Israel Englander's ABEO Position: Q2 2026 in Review

Israel Englander reduced its Abeona Therapeutics (ABEO) stake by 50% in Q2 2026, selling an estimated $1.18M and leaving 211,335 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #4140.

Israel Englander first reported a position in ABEO in Q1 2015 and has held it in 41 quarters since. The position peaked at $16.5M in Q2 2019. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Israel Englander held 211,335 shares of Abeona Therapeutics worth $1.31M as of Q2 2026.
  • Israel Englander sold 214,091 Abeona Therapeutics shares in Q2 2026, an estimated $1.18M.
  • Abeona Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4140 holding.
  • Israel Englander first reported a position in Abeona Therapeutics in Q1 2015 and has held it in 41 quarters since.
  • Israel Englander's Abeona Therapeutics position peaked at $16.5M in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.